Kezar Life Sciences raises $75M in slightly upsized IPO By: Silicon Valley Business Journal via Business Journals June 21, 2018 at 10:07 AM EDT The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 million shares for between $14 and $16. Read More >>